| Abstrakt: |
Keywords: Bariatrics; Chemistry; Cholesterol; Diet and Nutrition; Emerging Technologies; Health and Medicine; Hormones; Nanogels; Nanotechnology; Nutrition Disorders; Nutritional and Metabolic Diseases and Conditions; Obesity; Obesity and Diabetes; Overnutrition; University of Massachusetts Amherst EN Bariatrics Chemistry Cholesterol Diet and Nutrition Emerging Technologies Health and Medicine Hormones Nanogels Nanotechnology Nutrition Disorders Nutritional and Metabolic Diseases and Conditions Obesity Obesity and Diabetes Overnutrition University of Massachusetts Amherst 238 238 1 09/11/23 20230911 NES 230911 2023 SEP 14 (NewsRx) -- By a News Reporter-Staff News Editor at Diabetes Week -- A University of Massachusetts Amherst biomedical engineer has used a nanogel-based carrier designed in his lab to deliver a drug exclusively to the liver of obese mice, effectively reversing their diet-induced disease. Thyromimetics, or drugs that mimic synthetic thyroid hormone, have been considered as a potential way to tackle the problem of obesity, type 2 diabetes, high cholesterol, metabolic dysfunction-associated steatohepatitis (MASH) and other metabolic conditions. [Extracted from the article] |
